Where biotech is better off than anywhere else

(This article was published on June 18, 2012 by BostInnovation.) More than 15,000 people from around the world have descended upon Boston for the annual BIO International Convention. Among them are economic development officials hoping to entice companies to move to...

Novophage nabs $5.75M funding, names Rosenbloom as CEO

By Rodney H. Brown, Mass High Tech Novophage Inc., a startup that was known until March as Novophage Therapeutics Inc., has taken in $5.75 million in its first institutional funding round. The deal also brings on Micah Rosenbloom, co-founder of Bronte Technologies, as...